A study of analyst recommendations at the major brokerages shows that Johnson & Johnson (Symbol: JNJ) is the #10 broker pick, on average, out of the 30 stocks making up the Dow Jones Industrial Average, according to ETF Channel . Johnson & Johnson also comes in above the median of analyst picks among the broader S&P 500 index components, claiming the #120 spot out of 500. Below is a chart of rank over time: JNJ operates in the Drugs & Pharmaceuticals sector, among companies like Eli Lilly (LLY) which is up about 0.6% today, and Novartis (NVS) trading lower by about 0.2%. Below is a three month price history chart comparing the stock performance of JNJ, versus LLY and NVS. JNJ is currently trading up about 1.4% midday Tuesday.
We show the main point publicly. Create a free account to continue reading the full article, save it, discuss it, and connect it with market and OSINT context.